The BRCAscoop 2011 Hereditary Breast and Ovarian Cancer Research Report – Get Your Copy Now!
Are you a BRCA1 or BRCA2 mutation carrier? Or perhaps you know one – maybe a friend or family member? If so, you or someone you know may be interested in the following information. We are pleased to announce the widespread availability of The BRCAscoop 2011 Hereditary Breast and Ovarian Cancer Research Report for immediate download. It’s a wonderful way for BRCA1 and BRCA2...
Read MoreA New Online Tool for BRCA1 and BRCA2 Carriers
It’s great to have advanced to the point where women with risk for Hereditary Breast and Ovarian Cancer have important decisions to make about cancer prevention and screening that meaningfully impact their lives. Nevertheless, the decision-making is still fraught with challenges – whether it occurs in the context of advice from a high risk breast and ovarian cancer prevention clinic...
Read MoreMost Important BRCA1/BRCA2-Related Research Papers of 2011 – Nomination #6
Here is the 6th of 15 nominations from which we will select the 10 most important research papers for BRCA1/2 carriers discussed in the BRCAscoop 2011 Hereditary Breast and Ovarian Cancer Research Report: Dhar SU, Cooper HP, Wang T, et al. Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers. Breast Cancer Research and Treatment 2011;...
Read MoreMost Important BRCA1/BRCA2-Related Research Papers of 2011 – Nomination #1
Several days ago we announced that we will be releasing the BRCAscoop 2011 Hereditary Breast and Ovarian Cancer Research Report on February 15th – a close look at the implications of the most important new research papers of 2011 for BRCA1 and BRCA2 carriers. One by one, we will be announcing a total of 15 nominated papers from which the final list of 10 for the 2011 Research Report will be...
Read MoreWhen Was Your Last Mammogram?
When clinical researchers gauge to what extent women with BRCA1 and BRCA2 mutations are adhering to appropriate breast cancer screening recommendations, they often use self-reported information about mammogram frequency and dates. A new study by Dr. Michel Dorval (Université Laval, Quebec, Canada) and colleagues looked at whether self-reported mammography use at their institution was actually...
Read MoreChristina Applegate Foundation (Right Action for Women) and Patient Services, Inc. Partner to Provide Financial Assistance for Breast MRI for High-Risk Women
Right Action for Women (a partnership of The Christina Applegate Foundation and the Entertainment Industry Foundation) and Patient Services, Inc. (PSI) have announced a partnership to assist women at high-risk for breast cancer in finding the necessary financial resources for screening breast MRI. As many of you likely know, this is a central focus of The Christina Applegate Foundation, which...
Read MoreNew Research on Psychological Impact of Recall for More Imaging After a Breast MRI
The addition of breast MRI to mammograms is a key part of breast cancer screening and surveillance in women with BRCA1 or BRCA2 mutations. The increased sensitivity to detect cancers that may not be detectable by mammograms has a downside though: more false positives. On balance, for women with BRCA1/2 mutations, the benefits of breast MRI seem to outweigh the risks, but false positives can be an...
Read More
Recent Blog Post Comments